XWELL (NASDAQ:XWEL) Stock Price Up 10.3% – Here’s What Happened

XWELL, Inc. (NASDAQ:XWELGet Free Report) shares rose 10.3% during mid-day trading on Wednesday . The company traded as high as $1.21 and last traded at $1.18. Approximately 83,402 shares were traded during mid-day trading, a decline of 30% from the average daily volume of 118,791 shares. The stock had previously closed at $1.07.

Analyst Ratings Changes

XWEL has been the subject of a number of recent analyst reports. Wall Street Zen cut XWELL from a “hold” rating to a “sell” rating in a research report on Sunday, May 17th. Weiss Ratings cut XWELL from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, XWELL currently has a consensus rating of “Sell”.

Check Out Our Latest Analysis on XWEL

XWELL Stock Up 0.8%

The company has a market cap of $10.22 million, a P/E ratio of -0.22 and a beta of 1.01. The stock has a 50 day moving average price of $1.28 and a two-hundred day moving average price of $0.94.

XWELL (NASDAQ:XWELGet Free Report) last announced its earnings results on Wednesday, May 20th. The company reported ($1.51) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.00) by ($0.51). XWELL had a negative return on equity of 2,318.99% and a negative net margin of 81.43%.The firm had revenue of $6.64 million for the quarter, compared to the consensus estimate of $2.37 million.

XWELL Company Profile

(Get Free Report)

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.

Read More

Receive News & Ratings for XWELL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XWELL and related companies with MarketBeat.com's FREE daily email newsletter.